OABI Q3 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-23.8% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$20M-473.7% margin

Net Income

-$16M-392.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-45.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$332M

Total Liabilities

$40M

Stockholders' Equity

$292M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-23.8%
Gross Profit	$4M	$633,000	+559.1%
Operating Income	-$20M	-$20M	+2.6%
Net Income	-$16M	-$16M	-4.0%

Revenue Segments

Service

$2M89%

Royalty

$318,00011%